Funded Startups in Mont-saint-guibert
Five funded rounds are shown for Mont-saint-guibert, spanning 2022-11-03 (Novadip Biosciences, $23M) through 2024-04-18 (Cognivia, $17M), with the most rec…
Five funded rounds are shown for Mont-saint-guibert, spanning 2022-11-03 (Novadip Biosciences, $23M) through 2024-04-18 (Cognivia, $17M), with the most recent entry dated 2024-04-18. The disclosed amounts cluster in the high single-digits to low $20Ms, but Novadip Biosciences’ $23M (2022-11-03) stands out as the largest disclosed round, while the only smaller-but-still-material rounds are Celyad ($10M on 2023-08-24) and EsoBiotec ($2M on 2023-12-12). Sector concentration is strong: Biotechnology appears in 4 of the 5 rows (Cognivia, EsoBiotec, Celyad, Novadip Biosciences), with the remaining non-biotech entry being consumer electronics (e-peas, $19M on 2024-03-20). Stage/label mix is mixed as well, with “Series Unknown” appearing in 2 of 5 entries (Cognivia on 2024-04-18 and Celyad on 2023-08-24), while the remaining 3 include Series A (EsoBiotec), Series B (Novadip Biosciences), and a blank stage for e-peas (2024-03-20).
Most recent rounds
5 shownRelated listings
Frequently asked
Which disclosed round is largest in this Mont-saint-guibert slice, and how does it compare with the rest of the amounts shown?
Novadip Biosciences’ $23M round on 2022-11-03 is the largest disclosed amount in the table. The next-highest disclosed amount is e-peas at $19M (2024-03-20), while EsoBiotec’s $2M (2023-12-12) is the smallest disclosed round shown.
Do the most recent rounds cluster tightly in time, or are they spread out?
Within the 5 rows shown, 2 rounds fall in March–April 2024: e-peas ($19M on 2024-03-20) and Cognivia ($17M on 2024-04-18). The remaining rounds are spaced across 2023 (EsoBiotec on 2023-12-12 and Celyad on 2023-08-24) and 2022 (Novadip Biosciences on 2022-11-03).
Is biotechnology over-represented compared with other sectors in Mont-saint-guibert here?
Yes. Biotechnology accounts for 4 of 5 entries (Cognivia, EsoBiotec, Celyad, Novadip Biosciences), while the only other sector shown is Consumer Electronics via e-peas ($19M on 2024-03-20).
What stage naming pattern appears most often, and how many entries lack a disclosed series label?
“Series Unknown” appears in 2 of 5 rows: Cognivia ($17M on 2024-04-18) and Celyad ($10M on 2023-08-24). Separately, e-peas on 2024-03-20 shows a blank series field, while EsoBiotec (Series A, 2023-12-12) and Novadip Biosciences (Series B, 2022-11-03) have explicit stage labels.
Are there outliers in either amount size or sector within this list of 5?
There are two notable outliers on amount size: EsoBiotec’s $2M (2023-12-12) sits far below the others ($10M–$23M range for Cognivia, e-peas, Celyad, and Novadip Biosciences). In sector terms, e-peas is the only non-biotechnology entry ($19M on 2024-03-20) in this slice.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.